annual FCF:
-$44.17M+$8.25M(+15.74%)Summary
- As of today (June 17, 2025), JANX annual free cash flow is -$44.17 million, with the most recent change of +$8.25 million (+15.74%) on December 31, 2024.
- During the last 3 years, JANX annual FCF has fallen by -$25.71 million (-139.32%).
- JANX annual FCF is now -1053.94% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$17.39M-$628.00K(-3.75%)Summary
- As of today (June 17, 2025), JANX quarterly free cash flow is -$17.39 million, with the most recent change of -$628.00 thousand (-3.75%) on March 31, 2025.
- Over the past year, JANX quarterly FCF has dropped by -$2.36 million (-15.70%).
- JANX quarterly FCF is now -421.53% below its all-time high of $5.41 million, reached on March 31, 2021.
Performance
JANX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$46.53M-$2.36M(-5.34%)Summary
- As of today (June 17, 2025), JANX TTM free cash flow is -$46.53 million, with the most recent change of -$2.36 million (-5.34%) on March 31, 2025.
- Over the past year, JANX TTM FCF has increased by +$6.73 million (+12.63%).
- JANX TTM FCF is now -2527.44% below its all-time high of $1.92 million, reached on March 31, 2021.
Performance
JANX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
JANX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.7% | -15.7% | +12.6% |
| 3 y3 years | -139.3% | -39.2% | -28.0% |
| 5 y5 years | -1053.9% | -1885.7% | -5212.1% |
JANX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -139.3% | +15.7% | -671.0% | at low | -28.0% | +22.1% |
| 5 y | 5-year | -1053.9% | +15.7% | -421.5% | at low | -2527.4% | +22.1% |
| alltime | all time | -1053.9% | +15.7% | -421.5% | at low | -2527.4% | +22.1% |
JANX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$17.39M(+3.7%) | -$46.53M(+5.3%) |
| Dec 2024 | -$44.17M(-15.7%) | -$16.77M(+643.2%) | -$44.17M(+16.8%) |
| Sep 2024 | - | -$2.26M(-77.7%) | -$37.82M(-20.8%) |
| Jun 2024 | - | -$10.12M(-32.7%) | -$47.74M(-10.4%) |
| Mar 2024 | - | -$15.03M(+44.3%) | -$53.26M(+1.6%) |
| Dec 2023 | -$52.42M(+6.2%) | -$10.42M(-14.5%) | -$52.42M(-6.3%) |
| Sep 2023 | - | -$12.18M(-22.1%) | -$55.98M(-6.3%) |
| Jun 2023 | - | -$15.63M(+10.1%) | -$59.73M(+17.0%) |
| Mar 2023 | - | -$14.20M(+1.6%) | -$51.07M(+3.4%) |
| Dec 2022 | -$49.37M | -$13.97M(-12.3%) | -$49.37M(+4.9%) |
| Sep 2022 | - | -$15.93M(+128.6%) | -$47.05M(+27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.97M(-44.2%) | -$37.05M(+1.9%) |
| Mar 2022 | - | -$12.49M(+7.2%) | -$36.36M(+97.0%) |
| Dec 2021 | -$18.46M(+322.5%) | -$11.65M(+96.5%) | -$18.46M(+118.9%) |
| Sep 2021 | - | -$5.93M(-5.6%) | -$8.43M(+135.2%) |
| Jun 2021 | - | -$6.28M(-216.1%) | -$3.58M(-287.0%) |
| Mar 2021 | - | $5.41M(-432.1%) | $1.92M(-143.9%) |
| Dec 2020 | -$4.37M(+14.1%) | -$1.63M(+50.4%) | -$4.37M(+59.5%) |
| Sep 2020 | - | -$1.08M(+38.7%) | -$2.74M(+65.4%) |
| Jun 2020 | - | -$781.00K(-10.8%) | -$1.66M(+89.2%) |
| Mar 2020 | - | -$876.00K | -$876.00K |
| Dec 2019 | -$3.83M | - | - |
FAQ
- What is Janux Therapeutics annual free cash flow?
- What is the all time high annual FCF for Janux Therapeutics?
- What is Janux Therapeutics annual FCF year-on-year change?
- What is Janux Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Janux Therapeutics?
- What is Janux Therapeutics quarterly FCF year-on-year change?
- What is Janux Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Janux Therapeutics?
- What is Janux Therapeutics TTM FCF year-on-year change?
What is Janux Therapeutics annual free cash flow?
The current annual FCF of JANX is -$44.17M
What is the all time high annual FCF for Janux Therapeutics?
Janux Therapeutics all-time high annual free cash flow is -$3.83M
What is Janux Therapeutics annual FCF year-on-year change?
Over the past year, JANX annual free cash flow has changed by +$8.25M (+15.74%)
What is Janux Therapeutics quarterly free cash flow?
The current quarterly FCF of JANX is -$17.39M
What is the all time high quarterly FCF for Janux Therapeutics?
Janux Therapeutics all-time high quarterly free cash flow is $5.41M
What is Janux Therapeutics quarterly FCF year-on-year change?
Over the past year, JANX quarterly free cash flow has changed by -$2.36M (-15.70%)
What is Janux Therapeutics TTM free cash flow?
The current TTM FCF of JANX is -$46.53M
What is the all time high TTM FCF for Janux Therapeutics?
Janux Therapeutics all-time high TTM free cash flow is $1.92M
What is Janux Therapeutics TTM FCF year-on-year change?
Over the past year, JANX TTM free cash flow has changed by +$6.73M (+12.63%)